Amgen (AMGN): analysis and statistics
Return, volatility, Sharpe ratio and risk for Amgen, a component of both the S&P 500 and the Nasdaq 100 in the Health Care. Data as of 2026-10-29.
| Last close price | $451.83 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | +23.53% |
| Total return over period | +87.89% |
| Annualized volatility | 27.19% |
| Period volatility | 46.97% |
| Period T-bill | 12.40% |
| Sharpe ratio | 1.61 |
| Sortino ratio | 2.39 |
| Max drawdown | -22.74% |
| CVaR 95% (avg. loss, worst 5% of days) | -3.84% |
| Correlation with the S&P 500 | 0.28 |
| Period range | $235.08 – $451.83 |
| Trading days analyzed | 752 |
Over the last 3.0 years, Amgen (AMGN) has posted an annualized return of +23.53% with annual volatility of 27.19%, a Sharpe ratio of 1.61. Its worst stretch (max drawdown from a peak) was -22.74%. Its correlation with the S&P 500 is 0.28, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how AMGN would fit inside an optimized portfolio alongside other stocks, try the optimizer.
Optimize a portfolio with AMGN →
Other Health Care stocks
Is it part of the S&P 500?
Yes, Amgen (AMGN) is of both the S&P 500 and the Nasdaq 100.
What is the Sharpe ratio? · How to optimize an investment portfolio